| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Tumor necrosis factor|Cachectin|TNF-alpha|Tumor necrosis factor ligand superfamily member 2|TNF-a|Tumor necrosis factor, membrane form|N-terminal fragment|NTF|Intracellular domain 1|ICD1|Intracellular domain 2|ICD2|C-domain 1|C-domain 2|Tumor necrosis factor, soluble form|TNF|TNFA| TNFSF2 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
rabbit TNF-α (Tumor Necrosis Factor Alpha) is a molecular target commonly studied in immunology, cardiovascular, and cancer research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of TNF-α is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of TNF-α can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
TNF-α (Tumor Necrosis Factor Alpha) may also be referenced as Tumor necrosis factor, Cachectin, and TNF-alpha in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how TNF-α relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, cardiovascular, and cancer research.
- Interpreting shifts in TNF-α levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
TNF-α has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, cardiovascular, and cancer studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
In situ Preparation of a Phospholipid Gel Co-Loaded with Methotrexate and Dexamethasone for Synergistic Rheumatoid Arthritis Treatment
IF: 7.033 Journal: International Journal of Nanomedicine Cited Date: 2022-11-11
Combination Nanotherapeutics for Dry Eye Disease Treatment in a Rabbit Model
IF: 5.115 Journal: International Journal of Nanomedicine Cited Date: 2021-06-04
Injectable Thermosensitive Thiol-Modified NIPAAm--Chitosan Hydrogels for Cartilage Regeneration in a Rabbit Osteoarthritis Model
IF: 4.3 Journal: ACS Omega Author: Department of Biomedical Engineering, National Cheng Kung University, Tainan 70101, Taiwan. Cited Date: 2025-10-17
In vitro and in vivo amelioration of colitis using targeted delivery system of cyclosporine A in NewZealand rabbits
IF: 2.365 Journal: Drug Development and Industrial Pharmacy Cited Date: 2020-09-06
Amiloride Alleviates Neurological Deficits Following Transient Global Ischemia and Engagement of Central IL-6 and TNF-α Signal
IF: 2.196 Journal: Current Molecular Medicine Cited Date: 2019-09-15
The effect of budesonide delivered by high-frequency oscillatory ventilation on acute inflammatory response in severe lung injury in adult rabbits
IF: 2.103 Journal: Physiological Research Author: Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic Cited Date: 2024-01-12